343 related articles for article (PubMed ID: 29903784)
1. Designing PrEP and early HIV treatment interventions for implementation among female sex workers in South Africa: developing and learning from a formative research process.
Eakle R; Mutanha N; Mbogua J; Sibanyoni M; Bourne A; Gomez G; Venter F; Rees H
BMJ Open; 2018 Jun; 8(6):e019292. PubMed ID: 29903784
[TBL] [Abstract][Full Text] [Related]
2. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa.
Eakle R; Bourne A; Mbogua J; Mutanha N; Rees H
J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29457868
[TBL] [Abstract][Full Text] [Related]
3. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
[TBL] [Abstract][Full Text] [Related]
4. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H
PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874
[TBL] [Abstract][Full Text] [Related]
5. "Whatever is in the ARVs, is Also in the PrEP" Challenges Associated With Oral Pre-exposure Prophylaxis Use Among Female Sex Workers in South Africa.
Makhakhe NF; Sliep Y; Meyer-Weitz A
Front Public Health; 2022; 10():691729. PubMed ID: 35784260
[TBL] [Abstract][Full Text] [Related]
6. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.
Mboup A; Béhanzin L; Guédou FA; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Geidelberg L; Cianci F; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Boily MC; Vickerman P; Alary M
J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057
[TBL] [Abstract][Full Text] [Related]
7. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
[TBL] [Abstract][Full Text] [Related]
9. Uptake, retention, and outcomes in a demonstration project of pre-exposure prophylaxis among female sex workers in public health centers in Senegal.
Sarr M; Gueye D; Mboup A; Diouf O; Bao MDB; Ndiaye AJ; Ndiaye BP; Hawes SE; Tousset E; Diallo A; Jones F; Kane CT; Thiam S; Ndour CT; Gottlieb GS; Mboup S
Int J STD AIDS; 2020 Oct; 31(11):1063-1072. PubMed ID: 32819210
[TBL] [Abstract][Full Text] [Related]
10. HIV pre-exposure prophylaxis for female sex workers: ensuring women's family planning needs are not left behind.
Bowring AL; Ampt FH; Schwartz S; Stoové MA; Luchters S; Baral S; Hellard M
J Int AIDS Soc; 2020 Feb; 23(2):e25442. PubMed ID: 32064765
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
[TBL] [Abstract][Full Text] [Related]
12. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
[TBL] [Abstract][Full Text] [Related]
13. When are declines in condom use while using PrEP a concern? Modelling insights from a Hillbrow, South Africa case study.
Grant H; Mukandavire Z; Eakle R; Prudden H; B Gomez G; Rees H; Watts C
J Int AIDS Soc; 2017 Sep; 20(1):21744. PubMed ID: 28953330
[TBL] [Abstract][Full Text] [Related]
14. Prioritizing Risk in Preparation for a Demonstration Project: A Mixed Methods Feasibility Study of Oral Pre-Exposure Prophylaxis (PREP) among Female Sex Workers in South India.
Reza-Paul S; Lazarus L; Doshi M; Hafeez Ur Rahman S; Ramaiah M; Maiya R; Ms V; Venukumar KT; Sundararaman S; Becker M; Moses S; Lorway R
PLoS One; 2016; 11(11):e0166889. PubMed ID: 27880833
[TBL] [Abstract][Full Text] [Related]
15. "The Time Has Arrived": Perceptions of Behavioral Adjustments in the Context of Pre-Exposure Prophylaxis Availability Among Adolescents in South Africa.
Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
AIDS Educ Prev; 2018 Dec; 30(6):463-473. PubMed ID: 30966763
[TBL] [Abstract][Full Text] [Related]
16. Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis.
Stone J; Bothma R; Gomez GB; Eakle R; Mukandavire C; Subedar H; Fraser H; Boily MC; Schwartz S; Coetzee J; Otwombe K; Milovanovic M; Baral S; Johnson LF; Venter WDF; Rees H; Vickerman P
J Int AIDS Soc; 2023 Feb; 26(2):e26063. PubMed ID: 36807874
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
van der Straten A; Stadler J; Luecke E; Laborde N; Hartmann M; Montgomery ET;
J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
[TBL] [Abstract][Full Text] [Related]
18. A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in Côte d'Ivoire: the ANRS 12381 PRINCESSE project.
Becquet V; Nouaman M; Plazy M; Agoua A; Zébago C; Dao H; Montoyo A; Jary A; Coffie PA; Eholié S; Larmarange J;
BMC Public Health; 2021 Dec; 21(1):2214. PubMed ID: 34863122
[TBL] [Abstract][Full Text] [Related]
19. A Review of Pre-Exposure Prophylaxis Adherence among Female Sex Workers.
Ghayda RA; Hong SH; Yang JW; Jeong GH; Lee KH; Kronbichler A; Solmi M; Stubbs B; Koyanagi A; Jacob L; Oh H; Kim JY; Shin JI; Smith L
Yonsei Med J; 2020 May; 61(5):349-358. PubMed ID: 32390358
[TBL] [Abstract][Full Text] [Related]
20. Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation.
Chakrapani V; Newman PA; Shunmugam M; Mengle S; Varghese J; Nelson R; Bharat S
AIDS Patient Care STDS; 2015 Oct; 29(10):569-77. PubMed ID: 26348459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
